Circulating Lipids and COVID-19: Insights From Mendelian Randomization.
作者信息
Levin Michael G
机构信息
Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2811-2813. doi: 10.1161/ATVBAHA.121.316940. Epub 2021 Sep 30.
Abstract
摘要
相似文献
1
Circulating Lipids and COVID-19: Insights From Mendelian Randomization.循环脂质与2019冠状病毒病：孟德尔随机化研究的见解
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2811-2813. doi: 10.1161/ATVBAHA.121.316940. Epub 2021 Sep 30.
2
Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study.血脂与 COVID-19 风险之间的因果关系：两样本孟德尔随机化研究。
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2802-2810. doi: 10.1161/ATVBAHA.121.316324. Epub 2021 Sep 9.
3
Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.使用两样本孟德尔随机化方法评估致动脉粥样硬化性脂质相关性状对新型冠状病毒肺炎易感性和严重程度的因果效应。
BMC Med Genomics. 2021 Nov 13;14(1):269. doi: 10.1186/s12920-021-01127-2.
4
Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.COVID-19 宿主遗传学研究中的维生素 D 与 COVID-19 易感性和严重程度：一项孟德尔随机化研究。
PLoS Med. 2021 Jun 1;18(6):e1003605. doi: 10.1371/journal.pmed.1003605. eCollection 2021 Jun.
5
The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.血管紧张素转化酶水平对 COVID-19 易感性和严重程度的影响：一项孟德尔随机研究。
Int J Epidemiol. 2021 Mar 3;50(1):75-86. doi: 10.1093/ije/dyaa229.
6
Association between 25 Hydroxyvitamin D Concentrations and the Risk of COVID-19: A Mendelian Randomization Study.25-羟基维生素D浓度与新型冠状病毒肺炎风险的关联：一项孟德尔随机化研究
Biomed Environ Sci. 2021 Sep 20;34(9):750-754. doi: 10.3967/bes2021.104.
7
Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection.乳腺癌患者的血脂异常会增加 SARS-CoV-2 感染的风险。
Infect Genet Evol. 2021 Aug;92:104883. doi: 10.1016/j.meegid.2021.104883. Epub 2021 Apr 24.
8
Causal association between multiple sclerosis and severe COVID-19: A bidirectional Mendelian randomization study.多发性硬化症与重症 COVID-19 之间的因果关联：一项双向孟德尔随机化研究。
J Neuroimmunol. 2024 Jun 15;391:578352. doi: 10.1016/j.jneuroim.2024.578352. Epub 2024 Apr 30.
9
Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study.评估血浆脂质与腹主动脉瘤之间的关系：一项孟德尔随机化研究。
PLoS One. 2018 Apr 12;13(4):e0195719. doi: 10.1371/journal.pone.0195719. eCollection 2018.
10
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.全蛋白质组孟德尔随机化研究鉴定了血液蛋白与严重 COVID-19 之间的因果关系。
PLoS Genet. 2022 Mar 3;18(3):e1010042. doi: 10.1371/journal.pgen.1010042. eCollection 2022 Mar.
本文引用的文献
1
Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study.血脂与 COVID-19 风险之间的因果关系：两样本孟德尔随机化研究。
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2802-2810. doi: 10.1161/ATVBAHA.121.316324. Epub 2021 Sep 9.
2
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.血脂异常与 2019 年冠状病毒病（COVID-19）严重程度和死亡率的关系：一项荟萃分析。
Virol J. 2021 Jul 27;18(1):157. doi: 10.1186/s12985-021-01604-1.
3
Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.他汀类药物与住院 COVID-19 患者（伴或不伴糖尿病）的临床结局：一项基于倾向评分匹配的回顾性队列研究。
Cardiovasc Diabetol. 2021 Jul 10;20(1):140. doi: 10.1186/s12933-021-01336-0.
4
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.他汀类药物使用与 COVID-19 患者不良结局之间的保护关联：系统评价和荟萃分析。
PLoS One. 2021 Jun 24;16(6):e0253576. doi: 10.1371/journal.pone.0253576. eCollection 2021.
5
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.可操作的药物基因组全基因组孟德尔随机化确定了 COVID-19 的再利用机会。
Nat Med. 2021 Apr;27(4):668-676. doi: 10.1038/s41591-021-01310-z. Epub 2021 Apr 9.
6
Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.COVID-19 易感性和严重程度的心脏代谢危险因素：孟德尔随机分析。
PLoS Med. 2021 Mar 4;18(3):e1003553. doi: 10.1371/journal.pmed.1003553. eCollection 2021 Mar.
7
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.COVID-19 住院患者中使用他汀类药物前史与死亡率降低的关联。
Nat Commun. 2021 Feb 26;12(1):1325. doi: 10.1038/s41467-021-21553-1.
8
Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: A National Population-Based Cohort Study.他汀类药物在 COVID-19 相关结局中的有益作用-简要报告：一项全国基于人群的队列研究。
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):e175-e182. doi: 10.1161/ATVBAHA.120.315551. Epub 2021 Feb 4.
9
Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia.遗传中介的白细胞介素 6 受体抑制：与 COVID-19 和肺炎的相反关联。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.03545-2020. Print 2021 Jan.
10
Collider bias undermines our understanding of COVID-19 disease risk and severity.撞击器偏差破坏了我们对 COVID-19 疾病风险和严重程度的理解。
Nat Commun. 2020 Nov 12;11(1):5749. doi: 10.1038/s41467-020-19478-2.
Zotero 插件